Skip to main content

Biosimilars Market 2023 Industry Size, Share, Growth and Analysis by Demand, Opportunity, Key Players, Regional Development and Forecast 2029

By: SBWire

The global market for biosimilars is estimated to be worth around USD 15.60 billion in 2021, and it is expected to show significant growth, with a predicted rate of over 23.5% during the forecast period from 2022 to 2028.

London, UK -- (SBWIRE) -- 02/03/2023 -- Biosimilars Market Scope and Overview

Biosimilars are authorized versions of innovator drugs that can be manufactured after the original product's patent has expired. The market demand for biosimilars is driven by a range of factors, including the growing elderly population, the rising incidence of chronic diseases, the cost-effectiveness of biosimilar drugs, a more streamlined regulatory approval process, and the idea of interchangeability.

Biosimilars market research can help businesses gain a better understanding of their industry and develop successful plans for corporate growth. The market report combines primary and secondary research while taking both macro and micro environmental factors into account. The research delves into numerous factors identified as contributing to the market's growth trajectory. It contains market size, share, dynamics, and forecasts for the major segments and sub-segments.

Get Free Sample of Biosimilars Market @

Key Players Covered in Biosimilars market report are:

Samsung Biologics
Intas Pharmaceuticals Ltd.
Reliance Life Sciences
Pfizer, Inc.
Coherus BioSciences
Dr. Reddy's Laboratories Ltd.
Amgen, Inc.
Biocon Limited
Apotex, Inc.

The goal of the Biosimilars market research is to give participants the opportunity to learn about the most recent trends, current market conditions, and market-related technology. Future growth strategies for both new and incumbent market competitors, marketing channels, and market positioning are all covered in the strategy research.

Market Segmentation Analysis

The research report includes vital industry data, as well as tables and statistics to back up the analysis. It is an excellent source of information and assistance for businesses and anyone interested in the industry. To better understand market dynamics, the global Biosimilars market is divided into four segments: product type, application, geography, and end-use.

Biosimilars Market Segmentation as Follows:

By Product:
Monoclonal Antibodies
Granulocyte Colony-Stimulating Factor
Recombinant Human Growth Hormone
Enoxaparin Sodium

By Indication:
Inflammatory & Autoimmune Disorders
Chronic Diseases
Blood Disorders
Growth Hormone Deficiency
Infectious Diseases
Other Indications

Segmented by Region/Country
North America
Asia Other

Make an Inquiry about Biosimilars Market @

COVID-19 Pandemic Impact Analysis

The market research report discusses the COVID-19 epidemic and its effects on the Biosimilars market in great detail. The pandemic compelled this company to adapt and grow. In the aftermath of the global COVID-19 epidemic, this research paper examines the supply chain, import and export restrictions, regional government regulations, and the sector's potential ramifications.

Regional Outlook

The market research report focuses on the prospective region that is expected to generate opportunities in the global Biosimilars market in the coming years. This analysis will undoubtedly assist readers, stakeholders, and industry participants in gaining a comprehensive understanding of the global market and its potential for future growth.

Competitive Scenario

The global Biosimilars market is divided into segments based on company, market rate, competitive landscape, and most recent trends, such as consolidation, development, acquiring, and top firms' industry segments. The research report help to understand the competitive landscape and prepare the strategies accordingly.

Key Reasons to Purchase Biosimilars Market

- The research report is divided into sections that cover the qualitative and quantitative industrial characteristics of the target market's regions and nations.

- The report delves deeply into critical components such as driving forces and bottlenecks that will shape the market's future development.

- The market analysis examines and analyses the market's current and projected market landscape, as well as a current perspective on the ever-changing commercial zone.

Table of Content – Analysis of Key Points

Chapter 1. Executive Summary

Chapter 2. Global Market Definition and Scope

Chapter 3. Global Market Dynamics

Chapter 4. Global Biosimilars Market Industry Analysis

Chapter 5. Biosimilars Global Market, by Type

Chapter 6. Biosimilars Global Market, by Application

Chapter 7. Biosimilars Global Market, Regional Analysis

Chapter 8. Competitive Intelligence

Chapter 9. Key Companies Analysis

Chapter 10. Covid-19 Impact Analysis

Chapter 11. Russia-Ukraine War Consequence

Chapter 12. Risk Analysis of Global Recession in 2023

Chapter 13. Research Process


Buy Single User PDF @

For more information on this press release visit:

Media Relations Contact

Akash Anand
Head of Business Development & Strategy
Telephone: 44 20 8144 2758
Email: Click to Email Akash Anand

Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.